Literature DB >> 25845687

Increased Carbonic Anhydrase Activity is Associated with Sleep Apnea Severity and Related Hypoxemia.

Tengyu Wang1, Davoud Eskandari1, Ding Zou1, Ludger Grote1, Jan Hedner1.   

Abstract

STUDY
OBJECTIVES: The catalytic function of the enzyme carbonic anhydrase (CA) plays a fundamental role in carbon dioxide (CO2), proton (H(+)), and bicarbonate (HCO3(-)) homeostasis. Hypoxia and tissue acidosis have been proposed to increase physiological CA activity in various compartments of the body. We hypothesized that CA activity in blood is upregulated in patients with obstructive sleep apnea (OSA).
DESIGN: Cross-sectional analysis of a sleep clinic cohort. SETTINGS: Sleep laboratory at a university hospital. PARTICIPANTS: Seventy referred patients with suspected OSA (48 males, age 54 ± 13 y, apnea-hypopnea index (AHI) median [interquartile range] 21 [8-41] n/h).
INTERVENTIONS: N/A. MEASUREMENTS AND
RESULTS: In-laboratory cardiorespiratory polygraphy was used to assess OSA. CA activity was determined by an in vitro assay that quantifies the pH change reflecting the conversion of CO2 and H2O to HCO3(-) and H(+). CA activity was positively associated with AHI and 4% oxygen desaturation index (ODI4) (Spearman correlation r = 0.44 and 0.47, both P < 0.001). The associations (CA activity versus logAHI and CA versus logODI4) were independent of sex, age, body mass index, presleep oxygen saturation, nocturnal oxygen saturation, hypertension status, and use of diuretic medication in two generalized linear models (P = 0.007 and 0.011, respectively). Sitting diastolic blood pressure was associated with CA activity after adjustment of sex, age, body mass index, mean oxygen saturation, and AHI (P = 0.046).
CONCLUSIONS: Carbonic anhydrase (CA) activity increased with apnea-hypopnea index and related nocturnal hypoxemia measures in patients with obstructive sleep apnea (OSA). Altered CA activity may constitute a component that modulates respiratory control and hemodynamic regulation in patients with OSA.
© 2015 Associated Professional Sleep Societies, LLC.

Entities:  

Keywords:  blood pressure; carbonic anhydrase; intermittent hypoxia; obstructive sleep apnea

Mesh:

Substances:

Year:  2015        PMID: 25845687      PMCID: PMC4481006          DOI: 10.5665/sleep.4814

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  39 in total

1.  Combined effects of carbonic anhydrase inhibitor and adenosine A1 receptor antagonist on hemodynamic and tubular function in the kidney.

Authors:  Cynthia M Miracle; Timo Rieg; Roland C Blantz; Volker Vallon; Scott C Thomson
Journal:  Kidney Blood Press Res       Date:  2007-09-20       Impact factor: 2.687

2.  Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea.

Authors:  Bradley A Edwards; Scott A Sands; Danny J Eckert; David P White; James P Butler; Robert L Owens; Atul Malhotra; Andrew Wellman
Journal:  J Physiol       Date:  2012-01-04       Impact factor: 5.182

3.  Molecular CO 2 is inert on carotid chemoreceptor: demonstration by inhibition of carbonic anhydrase.

Authors:  D M Travis
Journal:  J Pharmacol Exp Ther       Date:  1971-09       Impact factor: 4.030

4.  Inhibition of carbonic anhydrase accounts for the direct vascular effects of hydrochlorothiazide.

Authors:  P Pickkers; R S Garcha; M Schachter; P Smits; A D Hughes
Journal:  Hypertension       Date:  1999-04       Impact factor: 10.190

5.  Intracellular pH and its regulation in isolated type I carotid body cells of the neonatal rat.

Authors:  K J Buckler; R D Vaughan-Jones; C Peers; P C Nye
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

6.  Renal carbonic anhydrases are involved in the reabsorption of endogenous nitrite.

Authors:  Kristine Chobanyan-Jürgens; Alexandra Schwarz; Anke Böhmer; Bibiana Beckmann; Frank-Mathias Gutzki; Jan T Michaelsen; Dirk O Stichtenoth; Dimitrios Tsikas
Journal:  Nitric Oxide       Date:  2012-01-20       Impact factor: 4.427

7.  Effects of acetazolamide on central blood pressure, peripheral blood pressure, and arterial distensibility at acute high altitude exposure.

Authors:  Gianfranco Parati; Miriam Revera; Andrea Giuliano; Andrea Faini; Grzegorz Bilo; Francesca Gregorini; Elisabetta Lisi; Sabrina Salerno; Carolina Lombardi; Carlos G Ramos Becerra; Giuseppe Mancia; Paolo Salvi
Journal:  Eur Heart J       Date:  2012-06-17       Impact factor: 29.983

8.  Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.

Authors:  Danny J Eckert; David P White; Amy S Jordan; Atul Malhotra; Andrew Wellman
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

9.  Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study.

Authors:  Davoud Eskandari; Ding Zou; Mahssa Karimi; Kaj Stenlöf; Ludger Grote; Jan Hedner
Journal:  Eur Respir J       Date:  2014-03-13       Impact factor: 16.671

10.  CARBONIC ANHYDRASE INJECTION PROVIDES EVIDENCE FOR THE ROLE OF BLOOD ACID-BASE STATUS IN STIMULATING VENTILATION AFTER EXHAUSTIVE EXERCISE IN RAINBOW TROUT

Authors: 
Journal:  J Exp Biol       Date:  1994-09       Impact factor: 3.312

View more
  8 in total

1.  Acetazolamide Reduces Blood Pressure and Sleep-Disordered Breathing in Patients With Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial.

Authors:  Davoud Eskandari; Ding Zou; Ludger Grote; Erik Hoff; Jan Hedner
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

Review 2.  Apneas of Heart Failure and Phenotype-Guided Treatments: Part One: OSA.

Authors:  Shahrokh Javaheri; Lee K Brown; William T Abraham; Rami Khayat
Journal:  Chest       Date:  2019-04-29       Impact factor: 9.410

Review 3.  Current and novel treatment options for obstructive sleep apnoea.

Authors:  Winfried Randerath; Jan de Lange; Jan Hedner; Jean Pierre T F Ho; Marie Marklund; Sofia Schiza; Jörg Steier; Johan Verbraecken
Journal:  ERJ Open Res       Date:  2022-06-27

4.  The Cerebellum and SIDS: Disordered Breathing in a Mouse Model of Developmental Cerebellar Purkinje Cell Loss during Recovery from Hypercarbia.

Authors:  Michele A Calton; Jeremy R Howard; Ronald M Harper; Dan Goldowitz; Guy Mittleman
Journal:  Front Neurol       Date:  2016-05-13       Impact factor: 4.003

5.  Independent associations between arterial bicarbonate, apnea severity and hypertension in obstructive sleep apnea.

Authors:  Davoud Eskandari; Ding Zou; Ludger Grote; Hartmut Schneider; Thomas Penzel; Jan Hedner
Journal:  Respir Res       Date:  2017-06-28

6.  A Novel Sulfonamide, 4-FS, Reduces Ethanol Drinking and Physical Withdrawal Associated With Ethanol Dependence.

Authors:  Muhammad Sona Khan; Wulfran Trenet; Nancy Xing; Britta Sibley; Muzaffar Abbas; Mariya Al-Rashida; Khalid Rauf; Chitra D Mandyam
Journal:  Int J Mol Sci       Date:  2020-06-21       Impact factor: 5.923

7.  Obstructive sleep apnea as an independent predictor of postoperative delirium and pain: protocol for an observational study of a surgical cohort.

Authors:  Patricia Strutz; William Tzeng; Brianna Arrington; Vanessa Kronzer; Sherry McKinnon; Arbi Ben Abdallah; Simon Haroutounian; Michael S Avidan
Journal:  F1000Res       Date:  2018-03-15

8.  Acetazolamide for OSA and Central Sleep Apnea: A Comprehensive Systematic Review and Meta-Analysis.

Authors:  Christopher N Schmickl; Shane A Landry; Jeremy E Orr; Kazuo Chin; Kimihiko Murase; Johan Verbraecken; Shahrokh Javaheri; Bradley A Edwards; Robert L Owens; Atul Malhotra
Journal:  Chest       Date:  2020-08-05       Impact factor: 9.410

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.